Dicoumarol was found to be the causative agent of a haemorrhagic disease in cattle following the ingestion of spoiled sweet clover. Vitamin K deficiency in chickens caused bleeding. Dicoumarol was later determined to be a vitamin K antagonist. A more potent form of the drug was produced synthetically and, following its initial use as rat poison, was recognized as a potential anti-thrombotic treatment in humans. The mode of action of a coumarin derivative (i.e. warfarin) is described. The overall effect of high-dose and low-dose warfarin and the possibility of a transient state of hypercoagulability on the introduction and withdrawal of treatment is considered.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00001721-199507000-00001 | DOI Listing |
J Thromb Haemost
September 2023
Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, California, USA. Electronic address:
Background: Mechanisms of iron clearance from hemophilic joints are unknown.
Objectives: To better understand mechanisms of iron clearance following joint bleeding in a mouse model of hemophilia.
Methods: Hemarthrosis was induced by subpatellar puncture in factor VIII (FVIII)-deficient (FVII) mice, +/- periprocedural recombinant human FVIII, and hypocoagulable (BALB/c) mice.
WMJ
March 2023
Wisconsin Northern and Central GME Consortium, Wausau, Wisconsin.
We present a case report highlighting a 47-year-old woman who developed warfarin-induced calciphylaxis. She initially developed bilateral leg wounds secondary to restraint straps from helicopter transportation to a higher level of care for treatment of critical aortic stenosis. She was started on warfarin following surgical implantation of a mechanical aortic valve.
View Article and Find Full Text PDFAnn Lab Med
July 2023
Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
Ann Pharmacother
October 2023
Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA.
Background: Essential to the coagulation pathway, vitamin K (phytonadione) is used to correct clotting factor deficiencies and for reversal of warfarin-induced bleeding. In practice, high-dose intravenous (IV) vitamin K is often used, despite limited evidence supporting repeated dosing.
Objective: This study sought to characterize differences in responders and nonresponders to high-dose vitamin K to guide dosing strategies.
Xenobiotica
May 2022
Department of Food Science, Aarhus Universitet, Aarhus, Denmark.
The anticoagulant drug warfarin is used treat atrial fibrillation. Several cases of drug-drug and drug-food interactions have been reported for warfarin.The aim of this study was to investigate the interaction between simultaneous administration of warfarin with the two ubiquitous flavonoids quercetin and curcumin.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!